An overactive AKT pathway is a characteristic of endometrial cancer and endometriosis; thus, regulation of PI3K/AKT signaling also became a consideration in the matter of therapeutic strategies for endometrial disorders [77]. This evidence concerns the gene AKT1 and endometriosis.